---
$id: https://graph.org.ai/products/commodity/51321706
$type: Product
source: UNSPSC
code: "51321706"
title: "Atorvastatin calcium"
class: "51321700"
classTitle: "Antihyperlipidemic and hypocholesterolemic fatty acids"
family: "51320000"
familyTitle: "Antihyperlipidemic and hypocholesterolemic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Atorvastatin calcium

**UNSPSC Code**: 51321706
**Class**: [Antihyperlipidemic and hypocholesterolemic fatty acids](Antihyperlipidemic and hypocholesterolemic fatty acids.mdx)
**Family**: [Antihyperlipidemic and hypocholesterolemic agents](../Antihyperlipidemic and hypocholesterolemic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a hmg-coa reductase inhibitor with the molecular formula 2C33H34FN2O5.Ca.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48A5M73Z4Q, chemically known as 1h-pyrrole-1-heptanoic acid, beta,delta-dihydroxy-2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, calcium salt (2:1), (r-(r*,r*))- but more generally known as atorvastatin calcium, which bears US NIH Compound Identifier 60822. European Medicines Agency schedules Atorvastatin calcium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12958MIG. Most nations, for tariff and trade purposes, schedule atorvastatin calcium under HS 29339990 and SITC 51577. Atorvastatin calcium bears US NLM identifiers UMLS ID C0286650 and NCI Concept Code C28837. SMILES: CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.CC(C)C1C(C(C(N1CC[C@H](C[C@H](CC(=O)[O-])O)O)C2CCC(CC2)F)C3CCCCC3)C(=O)NC4CCCCC4.O.O.O.[CA+2].

